Researchers at the University of Western Ontario have developed a Pulmonary Drug Delivery Technology Suite comprised of two innovative inventions for the precision measurement and dispensing of micro fine, dry powders. More

Aerosolized pharmaceutical composition with low potential toxicity, significantly reducing airway inflammation and remodelling More

BIS010 is a semi-synthetic plant origin polysaccharide demonstrating a potential modifying effect of the biologic activity of the joints. More

The development of a transdermal therapeutic system offers the advantages of constant plasma levels i.e. avoiding of plasma peaks and providing of therapeutic plasma level during the early morning hours More

1217B is a botanically derived potential drug candidate that inhibits the synthesis of several key pro-inflammatory mediators involved in the pathophysiology of allergic asthma and has been found to improve lung functionality in a mouse model. More

New substituted phenyl compounds useful for the treatment of respiratory disorders e.g. extrinsic or intrinsic or atopic asthma, chronic bronchitis, bronchiectasis and emphysema - multifunctional ?-agonist compounds comprising a reactive oxygen... More

New multifunctional steroid compound used for treating e.g. asthma, Alzheimer disease and psoriasis comprises steroid component, superoxide dismutase mimic component and optionally nitogen oxide donor component. More

A new Pyrimidinetrione Derivatives : Biphenyl-acylaminophenyl-piperazinyl-pyrimidinetrione derivatives, zinc metalloendopeptidases, matrix metalloproteinase, inflammation, cancer, angiogenesis. More